Synopsis: The Hyderabad-based pharma giant has given the green light to repurchase shares at ₹1,475 each, a 10% premium over the current market price. A major Indian pharma giant board approved a ₹800 crore share buyback on April 6, offering shareholders ₹1,475...
Synopsis:- Shares surged up to 6% after the government imposed minimum import prices on key antibiotic inputs. The move benefits the only domestic manufacturer with a 15,000-tonne capacity plant, operating at ~50% utilisation, expected to rise to 75%, improving...
Fundamental Analysis Of Aurobindo Pharma: Since the outbreak of the pandemic, there has been a greater emphasis on pharmaceutical companies due to the increased attention on global health concerns. One such company in this sector is Aurobindo Pharma. The company’s...
